Literature DB >> 19885240

Closed-loop control and advisory mode evaluation of an artificial pancreatic Beta cell: use of proportional-integral-derivative equivalent model-based controllers.

Matthew W Percival1, Howard Zisser, Lois Jovanovic, Francis J Doyle.   

Abstract

BACKGROUND: Using currently available technology, it is possible to apply modern control theory to produce a closed-loop artificial beta cell. Novel use of established control techniques would improve glycemic control, thereby reducing the complications of diabetes. Two popular controller structures, proportional-integral-derivative (PID) and model predictive control (MPC), are compared first in a theoretical sense and then in two applications.
METHODS: The Bergman model is transformed for use in a PID equivalent model-based controller. The internal model control (IMC) structure, which makes explicit use of the model, is compared with the PID controller structure in the transfer function domain. An MPC controller is then developed as an optimization problem with restrictions on its tuning parameters and is shown to be equivalent to an IMC controller. The controllers are tuned for equivalent performance and evaluated in a simulation study as a closed-loop controller and in an advisory mode scenario on retrospective clinical data.
RESULTS: Theoretical development shows conditions under which PID and MPC controllers produce equivalent output via IMC. The simulation study showed that the single tuning parameter for the equivalent controllers relates directly to the closed-loop speed of response and robustness, an important result considering system uncertainty. The risk metric allowed easy identification of instances of inadequate control. Results of the advisory mode simulation showed that suitable tuning produces consistently appropriate delivery recommendations.
CONCLUSION: The conditions under which PID and MPC are equivalent have been derived. The MPC framework is more suitable given the extensions necessary for a fully closed-loop artificial beta cell, such as consideration of controller constraints. Formulation of the control problem in risk space is attractive, as it explicitly addresses the asymmetry of the problem; this is done easily with MPC.

Entities:  

Keywords:  PID control; artificial pancreas; artificial pancreatic β cell; model predictive control; physiological modeling; type 1 diabetes mellitus

Year:  2008        PMID: 19885240      PMCID: PMC2769776          DOI: 10.1177/193229680800200415

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  16 in total

Review 1.  The intravenous route to blood glucose control.

Authors:  R S Parker; F J Doyle; N A Peppas
Journal:  IEEE Eng Med Biol Mag       Date:  2001 Jan-Feb

2.  A mathematical model of metabolic insulin signaling pathways.

Authors:  Ahmad R Sedaghat; Arthur Sherman; Michael J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11       Impact factor: 4.310

3.  Coefficients of normal blood glucose regulation.

Authors:  V W BOLIE
Journal:  J Appl Physiol       Date:  1961-09       Impact factor: 3.531

4.  A model-based algorithm for blood glucose control in type I diabetic patients.

Authors:  R S Parker; F J Doyle; N A Peppas
Journal:  IEEE Trans Biomed Eng       Date:  1999-02       Impact factor: 4.538

5.  Modeling insulin action for development of a closed-loop artificial pancreas.

Authors:  G M Steil; Bud Clark; Sami Kanderian; K Rebrin
Journal:  Diabetes Technol Ther       Date:  2005-02       Impact factor: 6.118

6.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT.

Authors:  Roman Hovorka; Fariba Shojaee-Moradie; Paul V Carroll; Ludovic J Chassin; Ian J Gowrie; Nicola C Jackson; Romulus S Tudor; A Margot Umpleby; Richard H Jones
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-05       Impact factor: 4.310

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Meal simulation model of the glucose-insulin system.

Authors:  Chiara Dalla Man; Robert A Rizza; Claudio Cobelli
Journal:  IEEE Trans Biomed Eng       Date:  2007-10       Impact factor: 4.538

9.  Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit.

Authors:  Rattan Juneja; Corbin Roudebush; Nilay Kumar; Angela Macy; Adam Golas; Donna Wall; Cheryl Wolverton; Deborah Nelson; Joni Carroll; Samuel J Flanders
Journal:  Diabetes Technol Ther       Date:  2007-06       Impact factor: 6.118

10.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  11 in total

1.  Algorithms for a closed-loop artificial pancreas: the case for model predictive control.

Authors:  B Wayne Bequette
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

2.  A novel adaptive basal therapy based on the value and rate of change of blood glucose.

Authors:  Youqing Wang; Matthew W Percival; Eyal Dassau; Howard C Zisser; Lois Jovanovic; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

3.  Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Authors:  Daniela Bruttomesso; Anne Farret; Silvana Costa; Maria Cristina Marescotti; Monica Vettore; Angelo Avogaro; Antonio Tiengo; Chiara Dalla Man; Jerome Place; Andrea Facchinetti; Stefania Guerra; Lalo Magni; Giuseppe De Nicolao; Claudio Cobelli; Eric Renard; Alberto Maran
Journal:  J Diabetes Sci Technol       Date:  2009-09-01

4.  Model-Fusion-Based Online Glucose Concentration Predictions in People with Type 1 Diabetes.

Authors:  Xia Yu; Kamuran Turksoy; Mudassir Rashid; Jianyuan Feng; Nicole Frantz; Iman Hajizadeh; Sediqeh Samadi; Mert Sevil; Caterina Lazaro; Zacharie Maloney; Elizabeth Littlejohn; Laurie Quinn; Ali Cinar
Journal:  Control Eng Pract       Date:  2018-02       Impact factor: 3.475

5.  Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.

Authors:  Jordan E Pinsker; Joon Bok Lee; Eyal Dassau; Dale E Seborg; Paige K Bradley; Ravi Gondhalekar; Wendy C Bevier; Lauren Huyett; Howard C Zisser; Francis J Doyle
Journal:  Diabetes Care       Date:  2016-06-11       Impact factor: 19.112

Review 6.  Glycemic Variability: Risk Factors, Assessment, and Control.

Authors:  Boris Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2019-01-29

7.  Quest for the artificial pancreas: combining technology with treatment.

Authors:  Rebecca A Harvey; Youqing Wang; Benyamin Grosman; Matthew W Percival; Wendy Bevier; Daniel A Finan; Howard Zisser; Dale E Seborg; Lois Jovanovic; Francis J Doyle; Eyal Dassau
Journal:  IEEE Eng Med Biol Mag       Date:  2010 Mar-Apr

Review 8.  Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.

Authors:  Boris P Kovatchev
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

Review 9.  Closed-loop insulin delivery: from bench to clinical practice.

Authors:  Roman Hovorka
Journal:  Nat Rev Endocrinol       Date:  2011-02-22       Impact factor: 43.330

10.  Response to Comment on Pinsker et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas. Diabetes Care 2016;39:1135-1142.

Authors:  Jordan E Pinsker; Joon Bok Lee; Eyal Dassau; Dale E Seborg; Paige K Bradley; Ravi Gondhalekar; Wendy C Bevier; Lauren Huyett; Howard C Zisser; Francis J Doyle
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.